Interconversion into a low active state protects vascular 5-HT2-receptors against irreversible antagonism by phenoxybenzamine.

Frenken, M

Interconversion into a low active state protects vascular 5-HT2-receptors against irreversible antagonism by phenoxybenzamine. [electronic resource] - Naunyn-Schmiedeberg's archives of pharmacology May 1987 - 481-90 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0028-1298

10.1007/BF00169112 doi


Allosteric Regulation
Animals
Binding Sites
Cattle
Coronary Vessels--metabolism
In Vitro Techniques
Ketanserin--pharmacology
Methysergide--pharmacology
Models, Biological
Muscle, Smooth, Vascular--metabolism
Phenoxybenzamine--pharmacology
Pulmonary Artery--metabolism
Receptors, Serotonin--drug effects